BONH
NVO

Bank of New Hampshire’s Novo Nordisk NVO Stock Holding History

Bank of New Hampshire’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719 Hold
15
– – ﹤0.01% 531
2026
Q1 		$551 Sell
15
-20,538
-100% -$973K ﹤0.01% 537
2025
Q4 		$1.05M Sell
20,553
-1,807
-8% -$92.4K 0.24% 93
2025
Q3 		$1.24M Sell
22,360
-210
-0.9% -$12.3K 0.29% 82
2025
Q2 		$1.56M Buy
22,570
+6,427
+40% +$437K 0.39% 74
2025
Q1 		$1.12M Buy
16,143
+1,699
+12% +$140K 0.29% 83
2024
Q4 		$1.24M Sell
14,444
-336
-2% -$36.3K 0.32% 79
2024
Q3 		$1.76M Buy
14,780
+648
+5% +$86.4K 0.44% 69
2024
Q2 		$2.02M Buy
14,132
+875
+7% +$116K 0.52% 51
2024
Q1 		$1.7M Buy
13,257
+12,347
+1,357% +$1.47M 0.45% 68
2023
Q4 		$94.1K Hold
910
– – 0.03% 258
2023
Q3 		$82.8K Hold
910
– – 0.02% 260
2023
Q2 		$73.6K Hold
910
– – 0.02% 271
2023
Q1 		$72.4K Hold
910
– – 0.02% 278
2022
Q4 		$62K Hold
910
– – 0.02% 293
2022
Q3 		$45K Hold
910
– – 0.01% 314
2022
Q2 		$51K Hold
910
– – 0.01% 309
2022
Q1 		$51K Buy
+910
New +$46.7K 0.01% 324

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Bank of New Hampshire's NVO Position: Q2 2026 in Review

Bank of New Hampshire held its Novo Nordisk (NVO) position steady in Q2 2026 at 15 shares worth $719. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Bank of New Hampshire first reported a position in NVO in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.02M in Q2 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Bank of New Hampshire held 15 shares of Novo Nordisk worth $719 as of Q2 2026.
  • Bank of New Hampshire left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Bank of New Hampshire's portfolio in Q2 2026, its #531 holding.
  • Bank of New Hampshire first reported a position in Novo Nordisk in Q1 2022 and has held it in 18 quarters since.
  • Bank of New Hampshire's Novo Nordisk position peaked at $2.02M in Q2 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.